These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 25269881)

  • 1. Morphology-based mammalian stem cell tests reveal potential developmental toxicity of donepezil.
    Lau CG; Marikawa Y
    Mol Reprod Dev; 2014 Nov; 81(11):994-1008. PubMed ID: 25269881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of In Vitro Morphogenesis of Mouse Embryoid Bodies to Assess Developmental Toxicity of Therapeutic Drugs Contraindicated in Pregnancy.
    Warkus EL; Yuen AA; Lau CG; Marikawa Y
    Toxicol Sci; 2016 Jan; 149(1):15-30. PubMed ID: 26385866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An in vitro gastrulation model recapitulates the morphogenetic impact of pharmacological inhibitors of developmental signaling pathways.
    Li AS; Marikawa Y
    Mol Reprod Dev; 2015 Dec; 82(12):1015-36. PubMed ID: 26387793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Embryoid body test with morphological and molecular endpoints implicates potential developmental toxicity of trans-resveratrol.
    Kim IQ; Marikawa Y
    Toxicol Appl Pharmacol; 2018 Sep; 355():211-225. PubMed ID: 29990529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human embryonic stem cell proliferation and differentiation as parameters to evaluate developmental toxicity.
    Pal R; Mamidi MK; Das AK; Bhonde R
    J Cell Physiol; 2011 Jun; 226(6):1583-95. PubMed ID: 20945368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse effect of valproic acid on an in vitro gastrulation model entails activation of retinoic acid signaling.
    Li AS; Marikawa Y
    Reprod Toxicol; 2016 Dec; 66():68-83. PubMed ID: 27693483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exposure-Based Validation of an In Vitro Gastrulation Model for Developmental Toxicity Assays.
    Warkus ELL; Marikawa Y
    Toxicol Sci; 2017 May; 157(1):235-245. PubMed ID: 28184906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of endoderm formation efficiency between mouse ES cells and iPS cells.
    Iwamuro M; Komaki T; Kubota Y; Seita M; Kawamoto H; Yuasa T; Shahid JM; Hassan RA; Hassan WA; Nakaji S; Nishikawa Y; Kondo E; Yamamoto K; Kobayashi N
    Cell Transplant; 2010; 19(6):831-9. PubMed ID: 20955658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental toxicity assessment of common excipients using a stem cell-based in vitro morphogenesis model.
    Yuan CJ; Marikawa Y
    Food Chem Toxicol; 2017 Nov; 109(Pt 1):376-385. PubMed ID: 28927898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoxetine Inhibits Canonical Wnt Signaling to Impair Embryoid Body Morphogenesis: Potential Teratogenic Mechanisms of a Commonly Used Antidepressant.
    Warkus ELL; Marikawa Y
    Toxicol Sci; 2018 Oct; 165(2):372-388. PubMed ID: 29893963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative assessment of toxic responses in 3D embryoid body differentiation model and mouse early embryos treated with 5-hydroxytryptophan.
    Gordeeva O; Gordeev A
    Arch Toxicol; 2021 Jan; 95(1):253-269. PubMed ID: 32926198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptomic characterization of C57BL/6 mouse embryonic stem cell differentiation and its modulation by developmental toxicants.
    Gao X; Yourick JJ; Sprando RL
    PLoS One; 2014; 9(9):e108510. PubMed ID: 25247782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of differentiation aspects by the morphological classification of embryoid bodies derived from human embryonic stem cells.
    Kim JM; Moon SH; Lee SG; Cho YJ; Hong KS; Lee JH; Lee HJ; Chung HM
    Stem Cells Dev; 2011 Nov; 20(11):1925-35. PubMed ID: 21388292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sonic hedgehog and other soluble factors from differentiating embryoid bodies inhibit pancreas development.
    Mfopou JK; De Groote V; Xu X; Heimberg H; Bouwens L
    Stem Cells; 2007 May; 25(5):1156-65. PubMed ID: 17272496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potency ranking of valproic acid analogues as to inhibition of cardiac differentiation of embryonic stem cells in comparison to their in vivo embryotoxicity.
    de Jong E; Doedée AM; Reis-Fernandes MA; Nau H; Piersma AH
    Reprod Toxicol; 2011 May; 31(4):375-82. PubMed ID: 21115111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dimethyl sulfoxide has an impact on epigenetic profile in mouse embryoid body.
    Iwatani M; Ikegami K; Kremenska Y; Hattori N; Tanaka S; Yagi S; Shiota K
    Stem Cells; 2006 Nov; 24(11):2549-56. PubMed ID: 16840553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmental toxicity of remdesivir, an anti-COVID-19 drug, is implicated by in vitro assays using morphogenetic embryoid bodies of mouse and human pluripotent stem cells.
    Kirkwood-Johnson L; Marikawa Y
    Birth Defects Res; 2023 Jan; 115(2):224-239. PubMed ID: 36349436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Embryoid bodies from mouse stem cells express oxytocin receptor, Oct-4 and DAZL.
    Stefanidis K; Loutradis D; Anastasiadou V; Beretsos P; Bletsa R; Dinopoulou V; Lekka K; Elenis E; Kiapekou E; Koussoulakos S; Fotinos A; Antsaklis A
    Biosystems; 2009 Nov; 98(2):122-6. PubMed ID: 19695304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of estrogen compounds on human embryoid bodies.
    Kim H; Kim YY; Ku SY; Kim SH; Choi YM; Moon SY
    Reprod Sci; 2013 Jun; 20(6):661-9. PubMed ID: 23184660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early gene expression changes during embryonic stem cell differentiation into cardiomyocytes and their modulation by monobutyl phthalate.
    van Dartel DA; Pennings JL; Hendriksen PJ; van Schooten FJ; Piersma AH
    Reprod Toxicol; 2009 Apr; 27(2):93-102. PubMed ID: 19162170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.